ProfusaPFSA -16.54%8 Net Debt Paydown Yield % is 2,566.84% as of Jul. 11, 2026, which is 925% above its 10-year median of 250.31. GuruFocus rates PFSA with a GF Score™ of 8/100. The stock has 3 warning signs investors should review. Among 772 Medical Devices & Instruments companies, Profusa ranks better than 99.74% on this metric.
Net Debt Paydown Yield % is a metric that evaluates the total amount of debt a company has paid in relation to its market capitalization. It is a measure of a company's willingness and ability to reduce its debt.
As of today, Profusa's Net Debt Paydown Yield % was 2,566.84%.
Profusa (NAS:PFSA) Net Debt Paydown Yield % Explanation
Net Debt Paydown Yield % is the change in average of four quarters of company's total debt over a company's market cap. Assuming the total value of a company remains that same, shareholder value is increased as debt is reduced. In other words, it is a measure of the willingness and ability of a firm's management to pay down debt. Companies that have high debt paydown yields indicate that they are more aggressive with paying down debt.
In the calculation of Net Debt Paydown Yield %, we use the reductions of TTM average total debt one-year-ago and TTM average total debt at present, divided by its Market Cap.
The historical data trend for Profusa's Net Debt Paydown Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PFSA vs ODYY, SSKN, NUMD: Net Debt Paydown Yield % Comparison
For the Medical Devices subindustry, Profusa's Net Debt Paydown Yield %, along with its competitors' market caps and Net Debt Paydown Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Profusa Net Debt Paydown Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Profusa's Net Debt Paydown Yield % distribution charts can be found below:
* The bar in red indicates where Profusa's Net Debt Paydown Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* All the data are calculated by TTM values. Note that if a companies is traded in several exchanges, then we calculate the company level data for Net Debt Paydown Yield % using the primary share class stock data. The calculation result in definition page is for demonstration purpose only, and it's showing the share class level data. Therefore, the numbers in the calculation may differ from elsewhere if the stock is not a primary share.
What does a Net Debt Paydown Yield % of 2,566.84% mean?
Profusa (PFSA) has a Net Debt Paydown Yield % of 2,566.84% as of Jul. 11, 2026. Net Debt Paydown Yield is a metric that evaluates the total amount of debt a company has paid in relation to its market capitalization. This metric provides insight into a company's willingness and ability to reduce its debt using free cash flow. View historical data on Profusa and its competitors. This is 925% above median its historical median of 250.31. Over the past decade, Profusa's Net Debt Paydown Yield % has ranged from 64.85 to 2,869.28. According to the industry distribution chart, Profusa ranks #2 out of 772 companies in the Medical Devices & Instruments industry, placing it in the top 0.3%.
Is Profusa's Net Debt Paydown Yield % too high?
Profusa's current Net Debt Paydown Yield % of 2,566.84% is 925% above median its 10-year median of 250.31. Over the past 10 years, this metric has ranged from a low of 64.85 to a high of 2,869.28. The Medical Devices & Instruments industry median Net Debt Paydown Yield % is 0.01. Profusa's value of 2,566.84% is 25668300% above this industry median. Based on the distribution chart, Profusa ranks #2 out of 772 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Profusa has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Profusa's Net Debt Paydown Yield % compare to ODYY and SSKN?
According to the Medical Devices & Instruments industry distribution chart, Profusa ranks #2 out of 772 companies for Net Debt Paydown Yield %. This places Profusa in the top 0% of its industry — outperforming the majority of peers. The industry median Net Debt Paydown Yield % is 0.01. Profusa's value of 2,566.84% is 25668300% above this benchmark. Historically, Profusa's own Net Debt Paydown Yield % has ranged from 64.85 to 2,869.28 over the past decade. While the company's 10-year median is 250.31 vs. the industry median of 0.01, Profusa has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Debt Paydown Yield % for a Medical Devices & Instruments company?
The median Net Debt Paydown Yield % among Medical Devices & Instruments companies is 0.01, based on 772 companies in the industry. Companies in the top quartile (top 25%) have a Net Debt Paydown Yield % significantly above this median, while those in the bottom quartile fall well below. However, Net Debt Paydown Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Profusa's current Net Debt Paydown Yield % of 2,566.84% is 25668300% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Debt Paydown Yield % mean?
A high Net Debt Paydown Yield % can signal that a stock is expensive relative to its fundamentals. Net Debt Paydown Yield is a metric that evaluates the total amount of debt a company has paid in relation to its market capitalization. This metric provides insight into a company's willingness and ability to reduce its debt using free cash flow. View historical data on Profusa and its competitors. For the Medical Devices & Instruments industry, the median Net Debt Paydown Yield % is 0.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Profusa's current Net Debt Paydown Yield % is 2,566.84%, which is 925% above median its own 10-year median of 250.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Profusa stock overvalued right now?
Profusa (PFSA) has a current Net Debt Paydown Yield % of 2,566.84%. The current Net Debt Paydown Yield % is 2,566.84%, which is 925% above median its 10-year median of 250.31 and 25668300% above the Medical Devices & Instruments industry median of 0.01. Profusa's overall GF Score™ is 8/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Debt Paydown Yield % calculated?
Net Debt Paydown Yield % is calculated from a company's financial statements. For Profusa (PFSA), the current Net Debt Paydown Yield % is 2,566.84% as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Profusa Inc is a clinical-stage digital health and medical technology company. The Company's technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. The Company's first offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term. The Lumee Oxygen Platform has been designed for use in applications where monitoring of compromised tissue is beneficial, such as peripheral artery disease that results in narrowing of blood vessels and reduced blood flow to the lower limbs; chronic wounds that do not heal properly; and reconstructive surgery.
8GF Score
Get the complete analysis for PFSA
Net Debt Paydown Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PFSA has been successfully added to your 
